My guess is that the next news release will be this coming Monday May 22 regarding their BioEquity Europe presentation that same day. I anticipate that this news release will also highlight the upcoming Resverlogix symposium on June 5th at ERA-EDTA entitled "Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?". Sure would be nice to get a news release on the financing end of things. I think it is still too early for the futility analysis or another DSMB report (last one was 2 months ago). 

BDAZ